Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Denver
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
On tenofovir and a ritonavir-boosted PI for at least 30 days initiating HCV treatment with SOF/LDV
HCV RNA \<48 copies/mL at most recent clinic visit
You may not be if
eGFR \< 60 ml/min
history of renal disease
Pregnant or planning pregnancy
Any medical, social, or mental-health issue(s) that, in the opinion of the investigators, could interfere with study participation or the study outcomes
